Article

Tuning Insulin Receptor Signaling Using De Novo Designed Agonists

medRxiv · 2024 · Wang, X.; Cardoso, S.; Cai, K.; Venkatesh, P.; Hung, A.; Ng, M.; Hall, C.; Coventry, B.; Lee, D.; Chowhan, R.; Gerben, S.; Li, J.; An, W.; Hon, M.; Accili, D.; Bai, X.; Choi, E.; Baker, D.

Key facts

Title Tuning Insulin Receptor Signaling Using De Novo Designed Agonists
First author Wang, X.; Cardoso, S.; Cai, K.; Venkatesh, P.; Hung, A.; Ng, M.; Hall, C.; Coventry, B.; Lee, D.; Chowhan, R.; Gerben, S.; Li, J.; An, W.; Hon, M.; Accili, D.; Bai, X.; Choi, E.; Baker, D.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.10.07.617068
Devices mentioned K042152, K940422, K982100
Product codes mentioned CFN, DFZ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature